Secondary cutaneous mucormycosis post-COVID-19: Case series from a tertiary center
Background: Mucormycosis is an angioinvasive mucorales fungal infection. Cutaneous type formed 10.5% of cases in India in precovid-19 era. Glucocorticoid-induced immunosuppression and hyperglycemia, reusable oxygen humidifiers in COVID-19 therapy, and preexisting uncontrolled diabetes mellitus contr...
Main Authors: | B Abhirami, Prabhat Kumar, Dharmendra Kumar Mishra, Satyendra Prasad Yadav |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Indian Journal of Dermatology |
Subjects: | |
Online Access: | http://www.e-ijd.org/article.asp?issn=0019-5154;year=2022;volume=67;issue=2;spage=206;epage=206;aulast=Abhirami |
Similar Items
-
Mucormycosis in patients with COVID-19: A descriptive study at a tertiary care hospital in North Maharashtra
by: Ganesh Shrihari Lokhande, et al.
Published: (2022-01-01) -
Fatal Disseminated Mucormycosis in a Hematological Immunocompromised Patient with Extensive Voriconazole Exposure: A Case Report and Review of the Literature
by: Victoria S. Humphrey, et al.
Published: (2020-10-01) -
Non-COVID-19 Cutaneous Mucormycosis from a Plastic Surgical Perspective
by: Vimalendu Brajesh, et al.
Published: (2023-08-01) -
Risk factors of mucormycosis in post-COVID-19 patients– A Retrospective study
by: Shaheen Zafar, et al.
Published: (2022-09-01) -
A Case of Primary Multifocal Cutaneous Mucormycosis in a Pediatric Patient with Newly Diagnosed Acute Lymphoblastic Leukemia
by: Denis Niyazi, et al.
Published: (2023-05-01)